https://www.selleckchem.com/pr....oducts/dorsomorphin-
45) or head and neck cancer (B 0.27), and those who reported a higher symptom burden (B 0.28/0.49). Both caregiver and patient factors were associated with reactions in FCs of cancer outpatients. This information can be used by healthcare personnel to identify FCs who need additional support (e.g. counselling), and to increase focus on strengths and assets within the caregivers (e.g. support groups). Both caregiver and patient factors were associated with reactions in FCs of cancer outpatients. This information can be used by